Phase 3 validation of PAaM for hepatocellular carcinoma risk stratification in cirrhosis. Fujiwara N, Lopez C, Marsh TL, Raman I, et al. Gastroenterology 2024 Nov 7:S0016-5085(24)05660.

Read + Share

Amedeo Smart

Independent Medical Education

Fujiwara N, Lopez C, Marsh TL, Raman I, et al. Phase 3 validation of PAaM for hepatocellular carcinoma risk stratification in cirrhosis. Gastroenterology 2024 Nov 7:S0016-5085(24)05660.
PMID: 39521255